Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Tobira Therapeutics (TBRA)

Tobira Therapeutics (TBRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Tobira Therapeutics 701 GATEWAY BLVD SUITE 300 SOUTH SAN FRANCISCO CA 94080

www.tobiratherapeutics.com P: 650-741-6625

Description:

Tobira Therapeutics, Inc. is a biopharmaceutical company. The Company is engaged in the development and commercialization of therapies to treat liver disease, inflammation, liver fibrosis and human immunodeficiency virus. Tobira Therapeutics, Inc., formerly known as Regado Biosciences, Inc., is headquartered in San Francisco, CA.

Key Statistics

Overview:

Market Capitalization, $K 787,090
Shares Outstanding, K 18,820
Annual Sales, $ 0 K
Annual Net Income, $ -49,620 K
Last Quarter Sales, $ 1,060 K
Last Quarter Net Income, $ -13,340 K
60-Month Beta -2.81
% of Insider Shareholders 6.20%
% of Institutional Shareholders 62.41%

Growth:

1-Year Return 317.56%
3-Year Return 2.78%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 11/08/16
Earnings Per Share ttm -2.46
EPS Growth vs. Prev Qtr -9.23%
EPS Growth vs. Prev Year 28.28%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-9 on 05/05/15

TBRA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -109.45%
Return-on-Assets % -71.32%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales 672.73
Price/Cash Flow N/A
Price/Book 24.96
Book Value/Share 1.05
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar